A novel pharmacodynamic assay to evaluate the effects of crystallization inhibitors on calcium phosphate crystallization in human plasma

Cardiovascular calcification (CVC) is a progressive complication of chronic kidney disease and a predictor of CV events and mortality. The use of biomarkers to predict CV risk and activities of potential or current treatment drugs in these patients could have a crucial impact on therapeutic approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrer, M. D., Pérez, M. M., Cànaves, M. M., Buades, J. M., Salcedo, C., Perelló, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537272/
https://www.ncbi.nlm.nih.gov/pubmed/28761091
http://dx.doi.org/10.1038/s41598-017-07203-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537272/
https://www.ncbi.nlm.nih.gov/pubmed/28761091
http://dx.doi.org/10.1038/s41598-017-07203-x

Ejemplares similares